Infinium Pharmachem (NSE:INFINIUM) Piotroski F-Score: 5 (As of Jul. 03, 2026) — Near Median


NSE:INFINIUM Infinium Pharmachem Ltd NSE:INFINIUM
86 GF Score
Price ₹204.30
GF Value ₹303.68
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Infinium Pharmachem Piotroski F-Score?

Infinium Pharmachem NSE:INFINIUM +2.15% 86 Piotroski F-Score is 5 as of Jul. 03, 2026, which is at its 10-year median of 5.00. GuruFocus rates NSE:INFINIUM with a GF Score™ of 86/100 and a GF Value™ of ₹303.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,564 Chemicals companies, Infinium Pharmachem ranks better than 55.31% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Infinium Pharmachem has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Infinium Pharmachem's Piotroski F-Score or its related term are showing as below:

NSE:INFINIUM' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 5

During the past 7 years, the highest Piotroski F-Score of Infinium Pharmachem was 8. The lowest was 2. And the median was 5.

Infinium Pharmachem  (NSE:INFINIUM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Infinium Pharmachem Piotroski F-Score Related Terms


Infinium Pharmachem Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Infinium Pharmachem's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinium Pharmachem Piotroski F-Score Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial 8.00 6.00 5.00 2.00 5.00

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 2.00 0.00 5.00

NSE:INFINIUM vs DOW: Piotroski F-Score Comparison

For the Chemicals subindustry, Infinium Pharmachem's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infinium Pharmachem Piotroski F-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Infinium Pharmachem's Piotroski F-Score falls into.


NSE:INFINIUM
86GF Score
Infinium Pharmachem Ltd NSE:INFINIUM
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹122 Mil.
Cash Flow from Operations was ₹337 Mil.
Revenue was ₹1,896 Mil.
Gross Profit was ₹411 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (1983.855 + 1749.36) / 2 = ₹1866.6075 Mil.
Total Assets at the begining of this year (Mar25) was ₹1,984 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Total Current Assets was ₹1,100 Mil.
Total Current Liabilities was ₹287 Mil.
Net Income was ₹81 Mil.

Revenue was ₹1,557 Mil.
Gross Profit was ₹381 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (854.527 + 1983.855) / 2 = ₹1419.191 Mil.
Total Assets at the begining of last year (Mar24) was ₹855 Mil.
Long-Term Debt & Capital Lease Obligation was ₹56 Mil.
Total Current Assets was ₹1,399 Mil.
Total Current Liabilities was ₹636 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Infinium Pharmachem's current Net Income (TTM) was 122. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Infinium Pharmachem's current Cash Flow from Operations (TTM) was 337. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=121.502/1983.855
=0.0612454

ROA (Last Year)=Net Income/Total Assets (Mar24)
=81.453/854.527
=0.0953194

Infinium Pharmachem's return on assets of this year was 0.0612454. Infinium Pharmachem's return on assets of last year was 0.0953194. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Infinium Pharmachem's current Net Income (TTM) was 122. Infinium Pharmachem's current Cash Flow from Operations (TTM) was 337. ==> 337 > 122 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/1866.6075
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=55.744/1419.191
=0.03927872

Infinium Pharmachem's gearing of this year was 0. Infinium Pharmachem's gearing of last year was 0.03927872. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1099.983/286.737
=3.83620879

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1399.169/635.913
=2.20025224

Infinium Pharmachem's current ratio of this year was 3.83620879. Infinium Pharmachem's current ratio of last year was 2.20025224. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Infinium Pharmachem's number of shares in issue this year was 15.577. Infinium Pharmachem's number of shares in issue last year was 14.545. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=410.854/1896.317
=0.21665892

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=381.056/1557.092
=0.24472286

Infinium Pharmachem's gross margin of this year was 0.21665892. Infinium Pharmachem's gross margin of last year was 0.24472286. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1896.317/1983.855
=0.9558748

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1557.092/854.527
=1.82216829

Infinium Pharmachem's asset turnover of this year was 0.9558748. Infinium Pharmachem's asset turnover of last year was 1.82216829. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Infinium Pharmachem has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Infinium Pharmachem (NSE:INFINIUM) has a Piotroski F-Score of 5 as of Jul. 03, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Infinium Pharmachem and its competitors. This is near median its historical median of 5.00. Over the past decade, Infinium Pharmachem's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Infinium Pharmachem ranks #699 out of 1564 companies in the Chemicals industry, placing it in the top 44.7%.
Is Infinium Pharmachem's Piotroski F-Score too high?
Infinium Pharmachem's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Chemicals industry median Piotroski F-Score is 5.00. Infinium Pharmachem's value of 5 is 0% at this industry median. Based on the distribution chart, Infinium Pharmachem ranks #699 out of 1564 companies in the Chemicals industry, which is above the industry midpoint. Overall, Infinium Pharmachem has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Piotroski F-Score compare to DOW?
According to the Chemicals industry distribution chart, Infinium Pharmachem ranks #699 out of 1564 companies for Piotroski F-Score. This puts Infinium Pharmachem in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Infinium Pharmachem's value of 5 is 0% at this benchmark. Historically, Infinium Pharmachem's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Infinium Pharmachem has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Chemicals company?
The median Piotroski F-Score among Chemicals companies is 5.00, based on 1,564 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Infinium Pharmachem's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Infinium Pharmachem and its competitors. For the Chemicals industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Infinium Pharmachem's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹303.68, compared to a current price of ₹204.30 — trading 32.7% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Chemicals industry median of 5.00. Infinium Pharmachem's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Piotroski F-Score is 5 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?

Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued. The current stock price of ₹204.30 is trading 32.7% below its estimated GF Value™ of ₹303.68. GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.

Key valuation signals for NSE:INFINIUM:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: ₹303.68 vs. price of ₹204.30 (32.7% below fair value)
  • GF Score™: 86/100 with 2 warning signs
  • Industry Position: 0% at the Chemicals median (#699 of 1564)

No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Infinium Pharmachem Business Description

Address V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
86GF Score

Get the complete analysis for NSE:INFINIUM

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹204.30
Price
₹303.68
GF Value